CN Patent

CN106279369B — 抗真菌剂及其应用

Assigned to Nap Pharmaceutical Group Co ltd · Expires 2020-02-11 · 6y expired

What this patent protects

本发明涉及一种抗真菌剂及其应用。本发明的特征为棘白菌素类化合物。所述化合物可用于真菌感染的治疗。

USPTO Abstract

本发明涉及一种抗真菌剂及其应用。本发明的特征为棘白菌素类化合物。所述化合物可用于真菌感染的治疗。

Drugs covered by this patent

rezafungin-acetate (REZAFUNGIN ACETATE)

Patent Metadata

Patent number: CN106279369B
Jurisdiction: CN
Classification: —
Expires: 2020-02-11
Drug substance claim: No
Drug product claim: No
Assignee: Nap Pharmaceutical Group Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.